Home  /  Resource Library  /  Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naive follicular lymphoma: Results from the phase II FLUORO study

Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naive follicular lymphoma: Results from the phase II FLUORO study

Results of a study investigating obinutuzumab and radiation therapy for first line treatment of follicular lymphoma.